A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.
- DOI
- 10.1136/bmjopen-2024-090013
- Published
- 2024 Nov 27
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2024-090013,
title = {A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.},
author = {Glen H and Bahl A and Fleure L and Clarke N and Jain S and Kalsi T and Khoo V and Mobeen J},
year = {2024},
journal = {BMJ open},
doi = {10.1136/bmjopen-2024-090013},
url = {https://doi.org/10.1136/bmjopen-2024-090013}
}RIS
TY - JOUR TI - A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK. AU - Glen H AU - Bahl A AU - Fleure L AU - Clarke N AU - Jain S AU - Kalsi T AU - Khoo V AU - Mobeen J PY - 2024 JO - BMJ open DO - 10.1136/bmjopen-2024-090013 UR - https://doi.org/10.1136/bmjopen-2024-090013 ER -
APA
H, G., A, B., L, F., N, C., S, J., T, K., V, K., & J, M. (2024). A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.. BMJ open. https://doi.org/10.1136/bmjopen-2024-090013
Source records
- pubmed · retrieved 2026-09-26T02:43:56.999Z